C-1000 TR

product on market Tablet or Pill MBi Nutraceuticals 🟢 Safety: 100/100
Brand: MBi Nutraceuticals
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 29% of ingredients have research evidence
B Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
60 Servings
Other Combinations Product Type
29% Evidence Coverage

Supplement Facts — Evidence Check

Calories
15 Calorie(s) (1% DV)
Vitamin C
1000 mg (1667% DV)
Rose Hips
60 mg
25 mg
📊 Market median: 500.0mg (19 products)
This product: 25mg
25 mg
📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)
This product: 25mg
Hesperidin
25 mg
25 mg
📊 Market median: 400.0mg (380 products) 📚 34 studies (Tier A: 1, B: 10)
This product: 25mg

Other Ingredients

Dextrose Vegetable Lubricants Magnesium Stearate Silica

Label Claims — Verification

❓ Nutrient
❓ All Other
All Other (99% of products) Structure/Function (83% of products) Nutrient (54% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommendation: Take one tablet per day or as directed by your health care professional.

⚠️ Warnings & Precautions

Warning: Keep out of the reach of children.

If tamper resistant seals are broken do not use this product.

🧪 Formulation Notes

C-1000 TR contains the finest Vitamin C and other bioflavonoid cofactors available. Boos immunity and use the natural healing powers of Vitamin C to correct skin problems or to maintain healthy skin. Vitamin C is also a known wound healer. TR means time released; this supplement won't be lost through excretion.

Additional Information

Bringing balance back to life

Product Details

UPC / SKU 3 58301 27117 0
DSLD Entry Date 2020-08-23
Product Type Other Combinations
Form Tablet or Pill
Brand MBi Nutraceuticals
DSLD ID 231549
Data Updated 2026-04-11

Research Evidence

371 Research Sources
54 Avg Quality Score
148 Meta Analysis
82 Systematic Review
71 Rct
62 Clinical Trial
2 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Other
1 Openfda Safety
A Vitamin C supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015
PubMed DOI Cochrane
A Vitamin C supplementation for the primary prevention of cardiovascular disease
Systematic Review The Cochrane database of systematic reviews 2017
PubMed DOI Cochrane
A Vitamin C for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI Cochrane
A Vitamin C for preventing and treating pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI Cochrane
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015
PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI Cochrane
A Vitamin C supplementation for prevention and treatment of pneumonia
Systematic Review The Cochrane database of systematic reviews 2021
PubMed DOI Cochrane
A Nutritional interventions for preventing and treating pressure ulcers
Meta Analysis The Cochrane database of systematic reviews 2024
PubMed DOI
A Does Vitamin C Supplementation Provide a Protective Effect in Periodontal Health? A Systematic Review and Meta-Analysis
Meta Analysis International journal of molecular sciences 2024
PubMed DOI
A Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study
Meta Analysis BMC medicine 2021
PubMed DOI
View all evidence for Vitamin C →

Compare Similar Products

OB Complete Chewable
OB Complete Chewable Vertical Pharmaceuticals 100
RenaPlex-D Nephro-Tech 100
800/Ultra D Dialyvite 100
B-Vital Higher Nature 100
Energise
Energise Higher Nature 100
View all Vitamin C products →
Vitamin C research & evidence Best Vitamin C rankings All Vitamin C products More from MBi Nutraceuticals View on NIH DSLD →